About Importin subunit alpha-4
Importin subunit alpha-4 (KPNA3) is a protein
from Homo sapiens identified by UniProt accession
O00505, 521 residues long.
MolForge cross-references it against 0 known binders and
65 disease associations.
Target properties
| Protein name | Importin subunit alpha-4 |
| UniProt accession | O00505 |
| Gene | KPNA3 |
| Organism | Homo sapiens |
| Length | 521 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (65)
Diseases linked to this target (Open Targets).
- influenza · score 0.46
- Autosomal dominant spastic paraplegia type 37 · score 0.37
- autosomal dominant pure spastic paraplegia · score 0.37
- reticulocyte count · score 0.37
- FEV/FVC ratio · score 0.35
- reticulocyte measurement · score 0.27
- Alzheimer disease · score 0.24
- Parkinson disease · score 0.24
- neurodegenerative disease · score 0.24
- lysosomal storage disease · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00505-F1 | alphafold | PREDICTED | 86.49 | — |
Amino-acid sequence (521 residues)
MAENPSLENH RIKSFKNKGR DVETMRRHRN EVTVELRKNK RDEHLLKKRN VPQEESLEDS DVDADFKAQN VTLEAILQNA TSDNPVVQLS AVQAARKLLS SDRNPPIDDL IKSGILPILV KCLERDDNPS LQFEAAWALT NIASGTSAQT QAVVQSNAVP LFLRLLRSPH QNVCEQAVWA LGNIIGDGPQ CRDYVISLGV VKPLLSFISP SIPITFLRNV TWVIVNLCRN KDPPPPMETV QEILPALCVL IYHTDINILV DTVWALSYLT DGGNEQIQMV IDSGVVPFLV PLLSHQEVKV QTAALRAVGN IVTGTDEQTQ VVLNCDVLSH FPNLLSHPKE KINKEAVWFL SNITAGNQQQ VQAVIDAGLI PMIIHQLAKG DFGTQKEAAW AISNLTISGR KDQVEYLVQQ NVIPPFCNLL SVKDSQVVQV VLDGLKNILI MAGDEASTIA EIIEECGGLE KIEVLQQHEN EDIYKLAFEI IDQYFSGDDI DEDPCLIPEA TQGGTYNFDP TANLQTKEFN F
Explore Importin subunit alpha-4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets